• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hematologic Neoplasms

Hematologic Neoplasms - 25 Studies Found

Completed : Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors
: Hematologic Neoplasms
: 2011-06-15
:
  • Drug: Cyclophosphamide 14.5 mg

Not yet recruiting : Prophylactic Early PN in HPT/BMT
: Hematologic Neoplasms
: 2017-03-08
:
  • Dietary Supplement: Parenteral nutrition.

Completed : A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
: Hematologic Neoplasms
: 2016-09-06
:
  • Drug: Itraconazole Participant

Completed : Platelet Transfusion Requirements in Hematopoietic Transplantation
: Hematologic Neoplasms
: 2016-01-06
: Drug: Tranexamic Acid
Completed : Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
: Hematologic Neoplasms
: 2015-11-30
: Procedure: Allogeneic (Allo) hematopoietic stem cell transplantation
Completed : Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units
: Hematologic Neoplasms
: 2015-07-17
: Procedure: T-Cell replete haplo-transplant Infusion of haploidentical related donor peripheral blood ste
Completed : Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
: Hematologic Neoplasms
: 2015-05-18
:
  • Biological: BPX-501 Biological

Completed : Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies
: Hematologic Neoplasms
: 2014-02-12
:
  • Biological: BMS-986016 Other N

Active, not recruiting : Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation
: Hematologic Neoplasms
: 2013-07-31
: Drug: AG-221 AG-221 administered orally on every day of 28 day cycles until disease progression or unacc
Active, not recruiting : Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
: Hematologic Neoplasms
: 2013-05-28
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.